Due to transition in the journal platform, the previously submitted articles, which are under process can be re-submitted here for quick process, kindly co-operate


Volume: 44 Issue: 1

  • Open Access
  • Original Article

A study on the prevalence and risk factors of coronary artery disease in patients with metabolic syndrome infected and not infected with COVID 19 from El- Oued (Algeria) region

Maroua Hammadi1, 2, Samir Derouiche1,2


1Department of Cellular and Molecular Biology, Faculty of the Sciences of Nature and Life El-Oued University, El-Oued 39000, El-Oued, Algeria
2Laboratory of Biodiversity and Application of Biotechnology in the Agricultural Field, University of El-Oued, El-Oued 39000, Algeria

Corresponding author: Samir Derouiche. Email: [email protected]


Year: 2024, Page: 89-95, Doi: https://doi.org/10.51248/.v44i1.4123

Received: Aug. 11, 2024 Accepted: Feb. 21, 2024 Published: May 1, 2024


Introduction and Aim: Coronary artery disease (CAD) is a pathological process described by atherosclerosis plaque in the epicardial arteries. CAD is a chronic process that begins during adolescence and slowly progresses through life. Several traditional risk factors genetics and environmental, involve in the development of atherosclerosis process. This study was aimed to investigate the prevalence of CAD and its associated risk factors among the El Oued (Algeria) population.
Materials and Methods: An epidemiological study was carried out on 23422 patients who suffered from cardiovascular diseases. The study of risk factors analysis was focused on 300 voluntary individuals, their origins from different El-Oued areas, and the CAD and metabolic syndrome patients selected from public and private health interests. All the information was obtained by a questionnaire. The risk of socio-clinical factors has been estimated by Binary Logistic regression was carried out between CVD and its associated risk factors. P < 0.05 from two-sided statistical tests was regarded as statistically significant.
Results: Through the results presented in our study, we found that the clinical factors such as hypertension (OR=154.846, and; P =0.000), the group aged> 60 (OR=154.84, and; P =0.000 and chest pain (OR=42.667, and; P =0.000), present significant risk factors with CAD patients compared to healthy people (control), respectively, in contrast we show that the most dangerous Socioeconomic factors alcohol consumption and stress respectively for (OR=13.500= and; P =0.001), and obesity (OR=4.495= and; P =0.000), but we estimate that sport is important protective factors for the disease with OR=52.6, P 0.500) in the CAD patients compared to metabolic syndrome patients.
Conclusion: The increasing prevalence of risk factors for coronary artery disease among the population has raised concerns for public health, which creates a health threat, especially with inadequate promotion and awareness programs.

Keywords: CAD; CVD; risk factors; protective factors; El-Oued.


1. Keates, A.K., Mocumbi, A.O., Ntsekhe, M., Sliwa, K., Stewart, S. Cardiovascular disease in Africa: Epidemiological profile and challenges., Nature Reviews Cardiology. 2017;14: 273-293.
2. Khan, M.A., Hashim M.J., Mustafa, H., Baniyas, M.Y., Al Suwaidi SKBM, AlKatheeri, R., et al., Global epidemiology of ischemic heart disease: Results from the Global Burden of Disease Study., Cureus. 2020;12:e9349.
3. Allioua, M., Djaziri, R., Mahdad, M.Y., Gaouar, S.B.S., Derradji, H., Boudjemaa, B.M., et al. Dietary fat intake, micronutrient and obesity among adolescent in Tlemcen (Western Algeria)., Food Nature and Science.2015;06:860-868.
4. Jariwala, P., Jadhav, K., Patil, R., Chawla, K. The prevalence of risk factors and pattern of obstructive coronary artery disease in young Indians (<45 years) undergoing percutaneous coronary intervention: A gender-based multi-center study., European Journal of Preventive Cardiology. 2022; 29:1-7.
5. Gaziano, T.A. Cardiovascular disease in the developing world and its cost-effective management., Circulation. 2005;112: 3547- 3553.
6. Zorca, S.M., Annette Mizuguchi, K. Coronary artery disease., In: Anesthesiology: Clinical Case Reviews. Springer International Publishing. 2017; 3-11.
7. Hatmi, Z.N., Tahvildari, S., Gafarzadeh Motlag, A., Sabouri Kashani, A. Prevalence of coronary artery disease risk factors in Iran: A population based survey., BMC Cardiovasc Disorder. 2007;7:3-7.
8. Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., et al., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 2006;113(6): e85-e151.
9. Pa, C.K. The effective history of critical theory: The reception history of Frankfurt school in Taiwan., Universitas (Stuttg). 2010; 37:111-125.
10. Almahmeed, W., Samir Arnaout, M., Chettaoui, R., Ibrahim, M., Ibrahim Kurdi, M., Awad Taher, M., et al., Coronary artery disease in Africa and the Middle East.,Therapeutics and Clinical Risk Management. 2012; 8:65-72.
11. Boussouf, K., Zaidi, Z., Kaddour, F., Djelaoudji, A., Benkobbi, S., Bayadi, N., et al., Clinical epidemiology of acute myocardial infarction in Setif, Algeria: Finding from the Setif-AMI Registry., Health Science Journal. 2019;13: 633.
12. Chute, C.G., Baron, J.A., Plymate, S.R., Kiel, D.P., Pavia, A.T., Lozner, E.C., et al., Sex hormones and coronary artery disease., American Journal of Medicine. 1987;83:853-859.
13. Malech, H.L., Garabedian, E.K., Hsieh, M.M. Evolution of gene therapy, historical perspective. Hematol Oncol Clin North Am. 2022;36(4):627-645.
14. Schildkraut, J.M., Myers, R.H., Cupples, L.A., Kiely, D.K., Kannel, W.B. Coronary risk associated with age and sex of parental heart disease in the Framingham Study., American of Journal Cardiology. 1989; 64:555-559.
15. Boukli Hacène, L., Khelil, M.A., Chabane Sari, D., Meguenni, K., Meziane Tani, A. Prévalence des facteurs de risque cardiovasculaire au sein des communautés urbaine et rurale dans la Wilaya de Tlemcen (Algérie) : l’étude de deux communes., Review of Epidemiology Sante Publique. 2017; 65:277-284.
16. Sagaro, G.G., Battineni, G., Camo, M. D., Minciacchi, A., Nittari, G., Amenta, F. A descriptive epidemiological study of cardiovascular diseases among seafarers., International Maritime Health. 2021;72:252-258.
17. Brørs, G., Dalen, H., Allore, H., Deaton, C., Fridlund, B., Osborne, R. H., et al., Health literacy and risk factors for coronary artery disease. The American journal of cardiology. 2022; 179: 22-30.
18. Szarpak, L., Mierzejewska, M., Jurek, J., Kochanowska, A., Gasecka, A., Truszewski, Z., et al., Effect of Coronary Artery Disease on COVID-19—Prognosis and Risk assessment: A systematic review and meta-analysis. 2022; 11(2):1-11.
19. Kundu, J., Kundu, S. Cardiovascular disease (CVD) and its associated risk factors among older adults in India: Evidence from LASI Wave 1. Clinical Epidemiology Globale Health. 2022;13:100-937.
20. Hajar, R. Genetics in cardiovascular disease. Heart Views. 2020;21(1):55-56.
21. Anderson, T.J., Grégoire, J., Hegele, R.A., Couture, P., Mancini, G.B.J., McPherson, R., et al., 2012 Update of the Canadian Cardiovascular society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult., Canadian Journal of Cardiology. 2013; 29:151-167.
22. Wan, Q., Qian, S., Huang, Y., Zhang, Y., Peng, Z., Li, Q., et al., Drug discovery for coronary artery disease. Advances in Experimental Medicine and Biology. 2020; 1177: 297-339.
23. Malakar, A.K., Choudhury, D., Halder, B., Paul, P., Uddin, A., Chakraborty, S. A review on coronary artery disease, its risk factors, and therapeutics. Journal of Cellular Physiology. 2019; 234:16812-16823.
24. Andersen, J.K., Oma, I., Prayson, R.A., Kvelstad, I.L., Almdahl, S.M., Fagerland, M.W., et al., Inflammatory cell infiltrates in the heart of patients with coronary artery disease with and without inflammatory rheumatic disease: A biopsy study., Arthritis Researchers and Therapy. 2016;18:1-10.
25. Mehta, S., Vijayvergiya, R., Dhawan, V. Activation of NLRP3 inflammasome assembly is associated with smoking status of patients with coronary artery disease., International Immunopharmacol. 2020; 87:106-820.
26. Chetehouna, S., Atoussi, O., Boulaares, I., Guemari I.Y., Derouiche, S. The effect of chronic tobacco smoking on atherogenic index and cardiovascular diseases risk in El-Oued (Algeria) men. Asian Journal of Research in Chemistry. 2020; 13(6): 1-7.
27. Neumann, F.J., Sechtem, U., Banning ,A.P., Bonaros, N., Bueno, H., Bugiardini, R., et al., 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes., European Heart Journal. 2020;41:407-477.

Cite this article

Maroua Hammadi, Samir Derouiche. A study on the prevalence and risk factors of coronary artery disease in patients with metabolic syndrome infected and not infected with COVID 19 from El- Oued (Algeria) region. Biomedicine: 2024; 44(1): 89-95